Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic Solution 0.025%. Brimonidine Tartrate Ophthalmic Solution 0.025% is the private label equivalent of Lumify in the US. Lumify, which is an over-the-counter (OTC) eyedrop, can be used for easing the […]
Slayback Pharma LLC has announced the launch of its new generic treatment for genital herpes, Generic Zovirax Ointment (Acyclovir Ointment) 5%, in the United States, marketed through an out-licensing agreement with Sandoz Inc., a generic pharmaceuticals subsidiary of Novartis AG. Strategic Partnership and Market Entry The launch follows the successful acquisition of an Abbreviated New […]